11.07.2015 Views

Download a PDF of the 2012 Annual Report - Black Dog Institute

Download a PDF of the 2012 Annual Report - Black Dog Institute

Download a PDF of the 2012 Annual Report - Black Dog Institute

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Pr<strong>of</strong>essor Colleen Loo demonstratingtranscranial Direct Current Stimulation(tDCS)Research activity from <strong>2012</strong> includes:Effects <strong>of</strong> brain stimulation on memoryand brain activity in depression – Advances innon-invasive electrical stimulation <strong>of</strong> ongoing brainactivity – such as transcranial direct current stimulation(tDCS) – continue to <strong>of</strong>fer new hope for <strong>the</strong> treatment<strong>of</strong> major depression. Yet <strong>the</strong> mechanisms <strong>of</strong> clinicalchange are unknown. In this study, we investigated <strong>the</strong>acute effects <strong>of</strong> tDCS treatment on cortical activity inpatients with depression whilst <strong>the</strong>y performed a difficultmemory task. The brain mechanisms measured inresponse to <strong>the</strong> task may indicate an improvement <strong>of</strong>selective attention directly after tDCS treatment. Thisstudy underlines <strong>the</strong> promise <strong>of</strong> functional brain imagingtests in understanding and monitoring response tobrain stimulation treatment.Ketamine as a neuroprotective agent inECT – This study investigated <strong>the</strong> neuroprotective andsynergistic effects <strong>of</strong> adjunctive sub-anaes<strong>the</strong>tic doses<strong>of</strong> <strong>the</strong> drug ketamine with ECT. Participants prescribedright-unilateral ultrabrief ECT were randomly assignedto receive ketamine or saline placebo with <strong>the</strong>ir anaes<strong>the</strong>siaand were assessed on cognitive, safety, andantidepressant efficacy outcomes. It was found that<strong>the</strong> addition <strong>of</strong> ketamine significantly increased <strong>the</strong>speed <strong>of</strong> antidepressant response over <strong>the</strong> first week<strong>of</strong> treatment – however efficacy outcomes were <strong>the</strong>same between ketamine and placebo by <strong>the</strong> end <strong>of</strong><strong>the</strong> ECT course. Ketamine was not shown to have anyneuroprotective advantage in this study. Finally, <strong>the</strong>use <strong>of</strong> adjunct sub-anaes<strong>the</strong>tic ketamine in this studydid not produce any significant psychomimetic sideeffects.BLACK DOG <strong>2012</strong>27

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!